Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC
ClinicalTrials.gov study NCT05116007. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
ClinicalTrials.gov study NCT06719583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
ClinicalTrials.gov study NCT03064854. IPD Sharing: NO. Countries: 12. Publications: 1.
Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117
ClinicalTrials.gov study NCT03325595. IPD Sharing: NO. Countries: 1. Publications: 1.
PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).
ClinicalTrials.gov study NCT07025681. IPD Sharing: YES. Countries: 1. Publications: 6.
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)
ClinicalTrials.gov study NCT04622007. IPD Sharing: NO. Countries: 3. Publications: 1.
MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
ClinicalTrials.gov study NCT03287427. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Research for the Molecular Imaging of the PD-L1 Targeting Tracer
ClinicalTrials.gov study NCT04304066. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC
ClinicalTrials.gov study NCT03912389. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04870905. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT04831658. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT02838823. IPD Sharing: YES. Countries: 1. Publications: 3.
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
ClinicalTrials.gov study NCT04172454. IPD Sharing: NO. Countries: 1. Publications: 1.
HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC
ClinicalTrials.gov study NCT03869034. IPD Sharing: YES. Countries: 1. Publications: 4.
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatme
ClinicalTrials.gov study NCT04860076. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers
ClinicalTrials.gov study NCT01051505. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT03565445. IPD Sharing: YES. Countries: 9. Publications: 1.
A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis
ClinicalTrials.gov study NCT02553889. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
ClinicalTrials.gov study NCT06086457. IPD Sharing: YES. Countries: 1. Publications: 3.
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT05245474. IPD Sharing: NO. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.